Rothschild & CO Asset Management Us Inc. Abb Vie Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 573,199 shares of ABBV stock, worth $101 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares

573,199

Previous 563,559 1.71%

Holding current value

$101 Million

Previous $75.6 Million 22.55%

% of portfolio

1.41%

Previous 1.29%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.33 Million - $1.6 Million	9,640 Added 1.71%	573,199 $92.7 Million
Q3 2022 Nov 07, 2022	SELL	$134.21 - $153.93 $5.67 Million - $6.5 Million	-42,251 Reduced 6.97%	563,559 $75.6 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $24.2 Million - $30.7 Million	-175,628 Reduced 22.47%	605,810 $92.8 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $2.05 Million - $2.55 Million	15,561 Added 2.03%	781,438 $127 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $1.55 Million - $1.96 Million	-14,397 Reduced 1.85%	765,877 $104 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $943,236 - $1.07 Million	-8,865 Reduced 1.12%	780,274 $84.2 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $3.14 Million - $3.49 Million	29,800 Added 3.92%	789,139 $88.9 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $2.05 Million - $2.25 Million	19,996 Added 2.7%	759,339 $82.2 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $26.7 Million - $36.1 Million	332,039 Added 81.52%	739,343 $79.2 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $14.6 Million - $17.1 Million	-169,507 Reduced 29.39%	407,304 $35.7 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $42.3 Million - $56.6 Million	576,811 New	576,811 $56.6 Million
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $16.7 Million - $19.7 Million	-216,893 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $20 Million - $24.7 Million	-257,492 Reduced 54.28%	216,893 $20 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $12.3 Million - $13.7 Million	-138,894 Reduced 22.65%	474,385 $44.9 Million
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $2.34 Million - $2.76 Million	26,016 Added 4.43%	613,279 $56.8 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $11.3 Million - $15.2 Million	-123,350 Reduced 17.36%	587,263 $55.6 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $62.8 Million - $68.8 Million	700,931 Added 7239.53%	710,613 $68.7 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $676,287 - $863,828	9,682	9,682 $860,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Abb Vie Inc. Transaction History